Raisio Group   Report issue

For profit
Founded: Raisio Finland (1939)
Status: No NME R&D (1939)

Organization Overview

First Clinical Trial
2005
NCT02628990
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Raisio Group | Raisio Nutrition Ltd.

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 11
  • # of Trial APIs: 5